The Damon Runyon Cancer Research Foundation announced the recipients of 2026 Damon Runyon-Rachleff Innovation Award. March 9, 2026 • By Damon Runyon Cancer Research Foundation ...

Therapeutic vaccines train the immune system to recognize and attack malignant cells.

Bishop Stacey Latimer, 63, was diagnosed with metastatic prostate cancer in 2019. He enrolled in a clinical trial and is still going strong.

Between the end of February and mid-August 2025, this first round of cuts to the NIH disrupted 383 studies testing treatments for cancer, heart disease, brain disease and more. In addition, of 11,008 ...

Meanwhile, across the country, members of the Los Angeles Pink Dragons, trained in the summer for the annual International Dragon Boat festival in Long Beach, California, held in July, and the 10 th ...

Luckily, a vast range of skilled and dedicated patient advocates can provide support to people with cancer and their loved ones. They raise funds and awareness, build programs and communities, share ...

Galleri, a blood test that aims to detect over 50 cancers, illustrates the promise and popularity of an emerging technology to screen for cancer. Although the blood test is not approved by the Food ...

The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in ...

Cancer survivorship begins at diagnosis and lasts a lifetime. It includes physical, emotional, social and financial well-being, not just the period after treatment ends. Research shows lifestyle ...

John Haanen, MD, PhD, of the Netherlands Cancer Institute in Amsterdam, and colleagues, in collaboration with Ugur Sahin’s team at BioNTech in Germany, tested a novel type of CAR-T therapy that ...

Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...

During chemotherapy, 29% of participants in the cooling group developed at least Grade 2 neuropathy in the frozen-glove hand, compared with 50% in the untreated hand. In the compression group, 24% had ...